Citations

Showing 10 of 108104 citations.

Feasibility of molecular profiling based assignment of cancer treatment (MPACT): A randomized NCI precision medicine study.
Chen, Alice P. , Williams, Mickey, Lih, Chih‐Jian, Datta, Vivekananda, Zhao, Yingdong , Meehan, Robert , Moore, Nancy, Harrington, Robin , Bouk, Courtney H., Harper, Kneshay N., Simon, Richard , Conley, Barbara A. , Doroshow, James H. , Kummar, Shivaani , Polley, Eric C. , Rubinstein, Larry , O'Sullivan Coyne, Geraldine , Sharon, Elad , Palmisano, Alida , Sims, David

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2539-2539

10.1200/jco.2016.34.15_suppl.2539 Get It

MRX34, a liposomal miR-34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase I trial of microRNA therapy.
Sachdev, Jasgit C. , Ejadi, Samuel, Kim, Tae‐You, Lim, Ho Yeong , Becerra, Carlos, Bader, Andreas G. , Stoudemire, Jay, Smith, Susan, Kim, Sinil, Beg, Muhammad Shaalan , Hong, David S. , Kang, Yoon‐Koo , Brenner, Andrew Jacob , Borad, Mitesh J. , Park, Keunchil , Smith, Susan

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2508-2508

10.1200/jco.2016.34.15_suppl.2508 Get It

Overall survival in patients with glioblastoma before and after bevacizumab approval.
Ravelo, Arliene , Sommer, Nicolas, Guérin, Annie , Ionescu‐Ittu, Raluca , Macalalad, Alexander R. , Shi, Sherry, Uhm, Joon H. , Johnson, Derek R. , Omuro, Antonio

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2062-2062

10.1200/jco.2016.34.15_suppl.2062 Get It

Prospective registry of multiplex testing (PROMPT): A web-based platform to assess cancer risk of genetic variants.
Walsh, Michael F. , Gaddam, Pragna, DiGiovanni, Laura , Dolinsky, Jill S. , Klein, Rachel , Lincoln, Stephen E. , Allen, Brian, Leighton, Justin, Strom, Charles M. , Ranger-Miller, Vanessa, Offit, Kenneth , Balmañà, Judith , Sittler, Taylor , Brown, Kyle, Garber, Judy E. , Couch, Fergus J. , Domchek, Susan M. , Robson, Mark E.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 1518-1518

10.1200/jco.2016.34.15_suppl.1518 Get It

Predictive value of topoisomerase 1 by immunohistochemistry (TOP1 IHC) in patients with metastatic breast cancer receiving irinotecan-based therapy.
Robert, Nicholas J. , Anthony, Stephen P. , Arguello, David, Jameson, Gayle , Northfelt, Donald W. , Jahanzeb, Mohammad , Petricoin, Emanuel F. , Dunetz, Bryant, Loesch, David, Pierobon, Mariaelena , Liotta, Lance A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 1037-1037

10.1200/jco.2016.34.15_suppl.1037 Get It

Academic and Community Cancer Research United (ACCRU) RU011301I: Adjuvant ado-trastuzumab emtansine (T-DM1) for older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
Polley, Mei‐Yin C. , Hurria, Arti , Muss, Hyman B. , Ruddy, Kathryn J. , Liu, Heshan , Rogak, Lauren J. , Basch, Ethan , Dakhil, Shaker R. , Huff, Jason D., Bajaj, Madhuri, Wilkinson, Mary, Baghadadi, Tareq Al, Benjamin, Sam, Mowat, Rex B., Hudis, Clifford A. , Freedman, Rachel A. , Dueck, Amylou C. , Hubbard, Joleen M. , Basch, Ethan , Rugo, Hope S. , Winer, Eric P. , Baghdadi, Tareq Al

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS629-TPS629

10.1200/jco.2016.34.15_suppl.tps629 Get It

Decreased copy number aberrations in genomes of HER2+ metastatic breast cancer (MBC) patients (pts) with extraordinary durable complete responses (dCR) to trastuzumab (T).
Maguire, Alanna , Gullo, Giuseppe , Quinn, Cecily , Malasi, Smriti, Lenkiewicz, Elizabeth, Barrett, Michael T. , O’Donovan, Norma , Walsh, Naomi , Crown, John

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 610-610

10.1200/jco.2016.34.15_suppl.610 Get It

Regional nodal irradiation after breast conserving surgery for HER2-positive breast cancer: Results of a sub analysis from the ALTTO trial.
Gingras, Isabelle, Holmes, Eileen , Nguyen, David H. , Izquierdo, Miguel , Zujewski, Jo Anne , Inbar, Moshe, Naume, Bjørn , Moreno‐Aspitia, Alvaro , Piccart, Martine , Azim, Hatem A. , Azambuja, Evandro de , Tomasello, Gianluca , Gnant, Michael

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 604-604

10.1200/jco.2016.34.15_suppl.604 Get It